11.700
+1,74%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -15.1% | -8.0% | 0 / 3 | +103.2% | -17.37 pp | -11.28 pp | — | 0.00 | 6.20 | 202 | +103,2% | 16,4 | −15,1% | 6.20 | 9.05 | −31,5% |
| Pts | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.700 (close price on 2026-10-19)EPS (TTM): 1.887
Financial charts
1.Revenue & growth
VND bn202Q2/26
1.Revenue & growth
VND bn202Q2/26
2.Profit & growth
VND bn16,4Q2/26
3.Profit mix (Penman)
VND bn86,8Q2/26
4.Margins & cost structure
%23.9%Q2/26
5.Returns & cash cycle
% · days20.6%Q2/26
6.Earnings quality & cash
VND bn-9,36Q2/26
7.Asset structure
VND bn686Q2/26
8.Funding & debt health
VND bn · times686Q2/26
9.Revenue backlog
VND bn36,6Q2/26
10.Valuation
times · %6,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %446Q2/26
Adjusted EPS growth, latest quarter
-15.1%
Average adjusted EPS growth, 3 quarters
-8.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26